Paediatric liver transplantation--a review based on 20 years of personal experience

Jean-Bernard Otte1

  • 1Unité de Chirurgie pédiatrique-Service de Transplantation Abdominale, Université Catholique de Louvain, Cliniques Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium. otte@chex.ucl.ac.be

Insights

Pediatric liver transplantation offers over 90% long-term survival. Optimizing timing and donor selection, alongside advancements in immunosuppression for operational tolerance, are key for better outcomes in children with chronic liver disease.

Area of Science:

  • Pediatric Hepatology
  • Transplant Surgery
  • Immunology

Background:

  • Chronic liver diseases in children necessitate liver replacement, with established natural histories.
  • Current pediatric liver transplantation achieves >90% long-term patient and graft survival.
  • Anticipating transplantation timing minimizes the impact of chronic liver disease on children.

Purpose of the Study:

  • To review the current state and future directions of pediatric liver transplantation.
  • To highlight the importance of donor selection and immunosuppression strategies.

Main Methods:

  • Review of existing literature on pediatric liver transplantation outcomes.
  • Analysis of factors influencing patient and graft survival.
  • Discussion of emerging immunosuppression protocols for operational tolerance.

Main Results:

  • Grafts from younger donors are associated with superior long-term patient and graft survival.
  • Live, related-donor transplantation is expected to increase due to donor shortages.
  • Advancements in immunosuppression leveraging the liver's immunological privilege are anticipated.

Conclusions:

  • Strategic timing and donor selection are crucial for successful pediatric liver transplantation.
  • Future progress hinges on refining immunosuppression to induce operational tolerance.
  • Continued development in live-donor protocols will address organ shortages.